Published in Ann Thorac Surg on February 01, 2010
Impact of the learning curve for endoscopic vein harvest on conduit quality and early graft patency. Ann Thorac Surg (2011) 1.56
Endoscopic harvesting device type and outcomes in patients undergoing coronary artery bypass surgery. Ann Surg (2014) 0.85
Is endoscopic harvesting bad for saphenous vein graft patency in coronary surgery? Curr Opin Cardiol (2011) 0.84
Mid-term outcomes for Endoscopic versus Open Vein Harvest: a case control study. J Cardiothorac Surg (2010) 0.83
Endoscopic vein harvesting: technique, outcomes, concerns & controversies. J Thorac Dis (2013) 0.83
Major themes for 2009 in cardiothoracic and vascular anesthesia. HSR Proc Intensive Care Cardiovasc Anesth (2010) 0.78
A randomized study comparing three groups of vein harvesting methods for coronary artery bypass grafting: endoscopic harvest versus standard bridging and open techniques. Interact Cardiovasc Thorac Surg (2012) 0.78
Early Outcomes of Endoscopic Vein Harvesting during the Initial Learning Period. Korean J Thorac Cardiovasc Surg (2015) 0.78
Endoscopic vein harvesting: does the learning curve influence outcomes? Ann Thorac Surg (2010) 0.77
A comprehensive review on learning curve associated problems in endoscopic vein harvesting and the requirement for a standardised training programme. J Cardiothorac Surg (2016) 0.75
Statistical methodology for analysis of endoscopic versus open saphenous vein harvest techniques. Ann Thorac Surg (2010) 0.75
Endoscopic vein harvesting is influenced by patient-related risk factors and may be of specific benefit in female patients. Interact Cardiovasc Thorac Surg (2013) 0.75
Endoscopic vein harvesting for coronary bypass grafting: a blessing or a trojan horse? Cardiol Res Pract (2011) 0.75
Comparative results of endoscopic and open methods of vein harvesting for coronary artery bypass grafting: a prospective randomized parallel-group trial. J Cardiothorac Surg (2015) 0.75
Traditional vein harvest yields the best graft patency rate. Ann Thorac Surg (2010) 0.75
Invited commentary. Ann Thorac Surg (2010) 0.75
Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med (2011) 10.29
Modeling the cardiac surgery workforce in Canada. Ann Thorac Surg (2010) 2.61
Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery. Circulation (2010) 2.31
Outcomes after aortic and mitral valve replacement surgery in Canada: 1994/95 to 1999/2000. Can J Cardiol (2004) 2.11
Insights from the STICH trial: change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction. J Thorac Cardiovasc Surg (2012) 2.10
Preoperative statin use and in-hospital outcomes following heart surgery in patients with unstable angina. Eur J Cardiothorac Surg (2005) 2.08
Minimally invasive mitral valve surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg (2008) 2.04
Identifying patients at risk of intraoperative and postoperative transfusion in isolated CABG: toward selective conservation strategies. Ann Thorac Surg (2004) 2.02
Coronary bypass surgery performed off pump does not result in lower in-hospital morbidity than coronary artery bypass grafting performed on pump. Circulation (2004) 1.95
Delirium: a cause for concern beyond the immediate postoperative period. Ann Thorac Surg (2011) 1.77
Preoperative atrial fibrillation decreases event-free survival following cardiac surgery. Eur J Cardiothorac Surg (2009) 1.76
Clopidogrel increases blood transfusion and hemorrhagic complications in patients undergoing cardiac surgery. Ann Thorac Surg (2010) 1.68
Robotic mitral valve repairs in 300 patients: a single-center experience. J Thorac Cardiovasc Surg (2008) 1.55
Fistulae of the internal thoracic vessels: report of two cases. Eur J Cardiothorac Surg (2002) 1.39
The cardiac surgery workforce: a survey of recent graduates of Canadian training programs. Ann Thorac Surg (2010) 1.35
The intraaortic balloon pump in cardiac surgery. Ann Thorac Surg (2002) 1.29
Use of valve surgery in Canada. Can J Cardiol (2004) 1.28
Minimally invasive video-assisted mitral valve surgery: a 12-year, 2-center experience in 1178 patients. J Thorac Cardiovasc Surg (2009) 1.25
Is it safe to train residents to perform cardiac surgery? Ann Thorac Surg (2002) 1.13
Delirium as a predictor of sepsis in post-coronary artery bypass grafting patients: a retrospective cohort study. Crit Care (2010) 1.13
A multicenter comparison of intraaortic balloon pump utilization in isolated coronary artery bypass graft surgery. Ann Thorac Surg (2003) 1.10
Training residents in mitral valve surgery. Ann Thorac Surg (2004) 1.08
Infectious endocarditis of a Chiari network. Ann Thorac Surg (2003) 1.01
Predicting in-hospital mortality after redo cardiac operations: development of a preoperative scorecard. Ann Thorac Surg (2012) 1.00
New onset postoperative atrial fibrillation is associated with a long-term risk for stroke and death following cardiac surgery. J Card Surg (2012) 1.00
Insulin induces myocardial protection and Hsp70 localization to plasma membranes in rat hearts. Am J Physiol Heart Circ Physiol (2006) 1.00
Conversion to on pump from OPCAB is associated with increased mortality: results from a randomized controlled trial. Eur J Cardiothorac Surg (2005) 0.99
Assessing the risk of waiting for coronary artery bypass graft surgery among patients with stenosis of the left main coronary artery. CMAJ (2005) 0.99
Evaluation of Mimesys phosphorylcholine (PC)-coated oxygenators during cardiopulmonary bypass in adults. J Extra Corpor Technol (2003) 0.98
Predicting prolonged intensive care unit length of stay in patients undergoing coronary artery bypass surgery--development of an entirely preoperative scorecard. Interact Cardiovasc Thorac Surg (2009) 0.98
Outcomes after coronary artery bypass graft surgery in Canada: 1992/93 to 2000/01. Can J Cardiol (2003) 0.96
The impact of new-onset atrial fibrillation on in-hospital mortality following cardiac surgery. Chest (2007) 0.93
The Canadian Society of Cardiac Surgeons perspective on the cardiac surgery workforce in Canada. Can J Cardiol (2012) 0.92
The association between prior percutaneous coronary intervention and short-term outcomes after coronary artery bypass grafting. Am Heart J (2005) 0.92
Prospective assessment of intraoperative precursor events during cardiac surgery. Eur J Cardiothorac Surg (2006) 0.92
The effect of place of residence on access to invasive cardiac services following acute myocardial infarction. Can J Cardiol (2009) 0.92
Long-term results of heart operations performed by surgeons-in-training. Circulation (2008) 0.90
Mitral insufficiency and morbidity and mortality in left ventricular dysfunction. Can J Cardiol (2007) 0.90
The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is not appropriate for withholding surgery in high-risk patients with aortic stenosis: a retrospective cohort study. J Cardiothorac Surg (2009) 0.89
Contribution of B cells and antibody to cardiac allograft vasculopathy. Transplantation (2009) 0.88
Bilateral internal thoracic artery grafting is superior to other forms of multiple arterial grafting in providing survival benefit after coronary bypass surgery. J Thorac Cardiovasc Surg (2012) 0.88
The preoperative intraaortic balloon pump in coronary bypass surgery: a lack of evidence of effectiveness. Am Heart J (2005) 0.87
Long-term outcomes in patients requiring stay of more than 48 hours in the intensive care unit following coronary bypass surgery. J Crit Care (2007) 0.85
Hemodynamic performance of the St. Jude Medical Epic Supra aortic stented valve. J Heart Valve Dis (2011) 0.85
IFN-gamma and Fas/FasL pathways cooperate to induce medial cell loss and neointimal lesion formation in allograft vasculopathy. Transpl Immunol (2009) 0.84
Complete revascularization is compromised in off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg (2012) 0.84
The dome of the left atrium: an alternative approach for mitral valve repair. Eur J Cardiothorac Surg (2003) 0.83
Aortic allograft vasculopathy is mediated by CD8(+) T cells in Cyclosporin A immunosuppressed mice. Transpl Immunol (2005) 0.83
CD8(+) T cells mediate aortic allograft vasculopathy under conditions of calcineurin immunosuppression: role of IFN-gamma and CTL mediators. Transpl Immunol (2008) 0.83
Effect of marriage on duration of chest pain associated with acute myocardial infarction before seeking care. CMAJ (2011) 0.82
Impact of preoperative angiotensin-converting enzyme inhibitor use on clinical outcomes after cardiac surgery. Ann Thorac Surg (2012) 0.82
Insulin-induced myocardial protection in isolated ischemic rat hearts requires p38 MAPK phosphorylation of Hsp27. Am J Physiol Heart Circ Physiol (2007) 0.82
Impact of admission serum glucose level on in-hospital outcomes following coronary artery bypass grafting surgery. Can J Cardiol (2010) 0.82
Preoperative statin use and outcomes following cardiac surgery. Int J Cardiol (2004) 0.81
Immunologic targets in the etiology of allograft vasculopathy: endothelium versus media. Transpl Immunol (2008) 0.80
Impact of cardiac intraoperative precursor events on adverse outcomes. Surgery (2007) 0.80
Preoperative cardiovascular risk factor control in elective coronary artery bypass graft patients: a failure of present management. Can J Cardiol (2002) 0.79
CD8+ T cells mediate aortic allograft vasculopathy by direct killing and an interferon-gamma-dependent indirect pathway. Cardiovasc Res (2005) 0.79
The impact of sequential grafting on clinical outcomes following coronary artery bypass grafting. Eur J Cardiothorac Surg (2010) 0.79
The effect of total arterial grafting on medium-term outcomes following coronary artery bypass grafting. J Cardiothorac Surg (2007) 0.79
Insulin potentiates expression of myocardial heat shock protein 70. Eur J Cardiothorac Surg (2004) 0.78
Impact of donor benign intimal thickening on cardiac allograft vasculopathy. J Heart Lung Transplant (2013) 0.78
Fibrinolysis versus primary percutaneous intervention in ST-elevation myocardial infarction with long interhospital transfer distances. Clin Cardiol (2010) 0.78
Cyclosporine immunosuppression does not prevent the production of donor-specific antibody capable of mediating allograft vasculopathy. J Heart Lung Transplant (2012) 0.78
Cardiac signaling molecules and plasma biomarkers after cardiac transplantation: impact of tacrolimus versus cyclosporine. J Heart Lung Transplant (2013) 0.76
Contribution of pre-existing vascular disease to allograft vasculopathy in a murine model. Transpl Immunol (2009) 0.76
Development of a predictive model for major adverse cardiac events in a coronary artery bypass and valve population. J Cardiothorac Surg (2013) 0.76
Recipient cells form the proliferative lesion in the rat heterotopic tracheal allograft model of obliterative airway disease. J Heart Lung Transplant (2003) 0.76
The effect of spironolactone use on heart failure mortality: a population-based study. J Card Fail (2007) 0.75
Unequal access to interventional cardiac care in Nova Scotia in patients with acute myocardial infarction complicated by cardiogenic shock. Can J Cardiol (2006) 0.75
Patient selection for minimally invasive aortic valve implantation. Eur J Cardiothorac Surg (2007) 0.75
Staged carotid and coronary surgery for concomitant carotid and coronary artery disease. Eur J Cardiothorac Surg (2002) 0.75
Endoscopic versus open saphenous vein harvest technique in the Randomized On/Off Bypass (ROOBY) trial. J Thorac Cardiovasc Surg (2011) 0.75
Predictors of implantable cardioverter-defibrillator use in patients with ischemic cardiomyopathy. Open Cardiovasc Med J (2010) 0.75